Anti-PD-1 monotherapy versus anti-PD1 plus anti-CTLA4 in advanced melanoma: how do we decide?
about
Anti-PD-1 monotherapy versus anti-PD1 plus anti-CTLA4 in advanced melanoma: how do we decide?
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2017
@uk
name
Anti-PD-1 monotherapy versus a ...... ed melanoma: how do we decide?
@en
Anti-PD-1 monotherapy versus a ...... ed melanoma: how do we decide?
@nl
type
label
Anti-PD-1 monotherapy versus a ...... ed melanoma: how do we decide?
@en
Anti-PD-1 monotherapy versus a ...... ed melanoma: how do we decide?
@nl
prefLabel
Anti-PD-1 monotherapy versus a ...... ed melanoma: how do we decide?
@en
Anti-PD-1 monotherapy versus a ...... ed melanoma: how do we decide?
@nl
P2093
P2860
P356
P1433
P1476
Anti-PD-1 monotherapy versus a ...... ed melanoma: how do we decide?
@en
P2093
Aine O'Reilly
James Larkin
P2860
P304
P356
10.2217/MMT-2017-0016
P407
P577
2017-09-01T00:00:00Z